Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Everything Else, Reduced, 2019 Q3, Page 5

CITADEL ADVISORS LLC historic quarter change: USA Everything Else, Reduced

In partnership units, exchange-traded notes and anything else (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 11,824 positions, added to 16,498, reduced 15,969 and sold out of 13,072.

  • Q3 2019: Stock ACELRX PHARMACEUTICALS INC; Country of operation —; Class Cmn; Shares before 80,214.
  • Q3 2019: Stock STERLING BANCORP INC; Country of operation —; Class Cmn; Shares before 40,965.
  • Q3 2019: Stock UBS AG JERSEY BRH; Country of operation —; Class Cmn; Shares before 17,645.
  • Q3 2019: Stock UNITED STS COMMODITY INDEX F; Country of operation —; Class Cmn; Shares before 13,769.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q3 2019ACELRX PHARMACEUTICALS INC
CUSIP 00444T100
—Cmn80,21458,707-21,507$203$129-$742019-11-14
Q3 2019STERLING BANCORP INC
CUSIP 85917W102
—Cmn40,96534,393-6,572$408$336-$722019-11-14
Q3 2019UBS AG JERSEY BRH
CUSIP 902641679
—Cmn17,64513,402-4,243$261$195-$662019-11-14
Q3 2019UNITED STS COMMODITY INDEX F
CUSIP 911717106
—Cmn13,76912,365-1,404$509$443-$662019-11-14
Q3 2019ADAMAS PHARMACEUTICALS INC
CUSIP 00548A106
—Cmn36,59232,601-3,991$226$167-$592019-11-14
Q3 2019CASA SYS INC
CUSIP 14713L102
—Cmn22,98311,306-11,677$147$89-$582019-11-14
Q3 2019CREDIT SUISSE NASSAU BRH
CUSIP 22542D480
—Cmn19,22912,913-6,316$172$116-$562019-11-14
Q3 2019TEEKAY OFFSHORE PARTNERS L P
CUSIP Y8565J101
—Cmn98,65859,066-39,592$124$69-$552019-11-14
Q3 2019KNOLL INC
CUSIP 498904200
—Cmn292,168267,044-25,124$6,715$6,769+$542019-11-14
Q3 2019PROTEOSTASIS THERAPEUTICS IN
CUSIP 74373B109
—Cmn122,09877,667-44,431$119$65-$542019-11-14
Q3 2019MINERVA NEUROSCIENCES INC
CUSIP 603380106
—Cmn74,75960,781-13,978$420$471+$512019-11-14
Q3 2019SESEN BIO INC
CUSIP 817763105
—Cmn49,57721,710-27,867$74$25-$492019-11-14
Q3 2019HTG MOLECULAR DIAGNOSTICS IN
CUSIP 40434H104
—Cmn38,52523,560-14,965$64$16-$482019-11-14
Q3 2019SGOCO GROUP LTD
CUSIP G80751129
—Cmn56,37319,283-37,090$58$18-$402019-11-14
Q3 2019KINGOLD JEWELRY INC
CUSIP 49579A204
—Cmn74,88511,837-63,048$46$7-$392019-11-14
Q3 2019REEBONZ HLDG LTD
CUSIP G7457R122
—Cmn13,62912,637-992$51$13-$382019-11-14
Q3 2019TENGASCO INC
CUSIP 88033R502
—Cmn60,78630,027-30,759$51$18-$332019-11-14
Q3 2019PROTALIX BIOTHERAPEUTICS INC
CUSIP 74365A101
—Cmn71,43415,812-55,622$34$3-$312019-11-14
Q3 2019VOXELJET AG
CUSIP 92912L107
—Depository Receipt70,23051,635-18,595$129$98-$312019-11-14
Q3 2019HIGHWAY HLDGS LTD
CUSIP G4481U106
—Cmn19,69814,944-4,754$56$26-$302019-11-14
Q3 2019NABRIVA THERAPEUTICS PLC
CUSIP G63637105
—Cmn29,12721,222-7,905$71$42-$292019-11-14
Q3 2019NANTKWEST INC
CUSIP 63016Q102
—Cmn46,50414,950-31,554$47$18-$292019-11-14
Q3 2019UBS AG LONDON BRH
CUSIP 902677780
—Cmn1,1831,057-126$321$293-$282019-11-14
Q3 2019AETHLON MED INC
CUSIP 00808Y208
—Cmn83,53310,223-73,310$30$2-$282019-11-14
Q3 2019UBS AG LONDON BRH
CUSIP 90274D234
—Cmn1,9951,905-90$333$306-$272019-11-14
Q3 2019KANDI TECHNOLOGIES GROUP INC
CUSIP 483709101
—Cmn44,21640,972-3,244$218$191-$272019-11-14
Q3 2019EAGLE PHARMACEUTICALS INC
CUSIP 269796108
—Cmn52,74852,397-351$2,937$2,963+$262019-11-14
Q3 2019INFINITY PHARMACEUTICALS INC
CUSIP 45665G303
—Cmn29,99127,434-2,557$54$28-$262019-11-14
Q3 2019GENOCEA BIOSCIENCES INC
CUSIP 372427401
—Cmn17,29014,473-2,817$68$42-$262019-11-14
Q3 2019FUELCELL ENERGY INC
CUSIP 35952H601
—Cmn407,171141,192-265,979$72$46-$262019-11-14
Q3 2019SEQUANS COMMUNICATIONS S A
CUSIP 817323108
—Depository Receipt65,31240,151-25,161$59$35-$242019-11-14
Q3 2019T2 BIOSYSTEMS INC
CUSIP 89853L104
—Cmn37,08915,304-21,785$62$38-$242019-11-14
Q3 2019MORGAN STANLEY
CUSIP 617480280
—Cmn4,2204,205-15$260$284+$242019-11-14
Q3 2019CAPITAL SR LIVING CORP
CUSIP 140475104
—Cmn25,28223,678-1,604$127$104-$232019-11-14
Q3 2019STAGE STORES INC
CUSIP 85254C305
—Cmn18,17518,135-40$14$34+$202019-11-14
Q3 2019CELSION CORPORATION
CUSIP 15117N503
—Cmn37,67532,585-5,090$69$50-$192019-11-14
Q3 2019NEWLINK GENETICS CORP
CUSIP 651511107
—Cmn46,22831,555-14,673$68$50-$182019-11-14
Q3 2019MAIDEN HOLDINGS LTD
CUSIP G5753U112
—Cmn223,894168,136-55,758$143$126-$172019-11-14
Q3 2019EQUUS TOTAL RETURN INC
CUSIP 294766100
—Cmn25,65715,411-10,246$41$25-$162019-11-14
Q3 2019KADMON HLDGS INC
CUSIP 48283N106
—Cmn154,035132,236-21,799$317$333+$162019-11-14
Q3 2019CITIGROUP INC NEW
CUSIP 17321F201
—Cmn11,62911,036-593$157$141-$162019-11-14
Q3 2019LIANLUO SMART LTD
CUSIP G5478K100
—Cmn21,47816,668-4,810$27$11-$162019-11-14
Q3 2019BOXLIGHT CORP
CUSIP 103197109
—Cmn10,64710,121-526$33$19-$142019-11-14
Q3 2019NEPTUNE WELLNESS SOLUTIONS I
CUSIP 64079L105
—Cmn17,14917,133-16$75$61-$142019-11-14
Q3 2019CHINA RECYCLING ENERGY CORP
CUSIP 168913200
—Cmn47,88116,269-31,612$20$6-$142019-11-14
Q3 2019PIXELWORKS INC
CUSIP 72581M305
—Cmn41,59029,325-12,265$123$109-$142019-11-14
Q3 2019PORTMAN RIDGE FIN CORP
CUSIP 73688F102
—Cmn18,90312,954-5,949$43$29-$142019-11-14
Q3 2019VISLINK TECHNOLOGIES INC
CUSIP 92836Y201
—Cmn12,59111,479-1,112$20$6-$142019-11-14
Q3 2019HEARTLAND FINL USA INC
CUSIP 42234Q102
—Cmn37,97437,707-267$1,699$1,687-$122019-11-14
Q3 2019TANZANIAN GOLD CORP
CUSIP 87601A107
—Cmn33,52320,971-12,552$29$17-$122019-11-14
Q3 2019FUTURE FINTECH GROUP INC
CUSIP 36117V105
—Cmn26,97325,841-1,132$33$21-$122019-11-14
Q3 2019DAVIDSTEA INC
CUSIP 238661102
—Cmn31,36625,015-6,351$41$52+$112019-11-14
Q3 2019CELGENE CORP
CUSIP 151020112
—Cmn85,20774,217-10,990$53$42-$112019-11-14
Q3 2019TAOPING INC
CUSIP G8675V101
—Cmn22,34111,277-11,064$16$6-$102019-11-14
Q3 2019JPMORGAN CHASE FINL CO LLC
CUSIP 48129G703
—Cmn10,26810,254-14$175$165-$102019-11-14
Q3 2019SPI ENERGY CO LTD
CUSIP G8651P110
—Cmn12,56710,231-2,336$27$37+$102019-11-14
Q3 2019ALASKA COMMUNICATIONS SYS GR
CUSIP 01167P101
—Cmn17,10011,003-6,097$29$19-$102019-11-14
Q3 2019EMAGIN CORP
CUSIP 29076N206
—Cmn35,08915,856-19,233$16$6-$102019-11-14
Q3 2019INDUSTRIAL SVCS OF AMERICA I
CUSIP 456314103
—Cmn26,09815,115-10,983$26$17-$92019-11-14
Q3 2019STEIN MART INC
CUSIP 858375108
—Cmn82,56077,469-5,091$71$62-$92019-11-14
Q3 2019U S GOLD CORP
CUSIP 90291C102
—Cmn19,15313,420-5,733$20$12-$82019-11-14
Q3 2019AQUA METALS INC
CUSIP 03837J101
—Cmn51,09945,069-6,030$85$77-$82019-11-14
Q3 2019CVR PARTNERS LP
CUSIP 126633106
—Cmn25,83725,183-654$106$98-$82019-11-14
Q3 2019AMPIO PHARMACEUTICALS INC
CUSIP 03209T109
—Cmn64,87864,663-215$25$32+$72019-11-14
Q3 2019INNERWORKINGS INC
CUSIP 45773Y105
—Cmn321,837279,151-42,686$1,230$1,237+$72019-11-14
Q3 2019FORWARD PHARMA A/S
CUSIP 34986J105
—Depository Receipt17,08110,812-6,269$18$11-$72019-11-14
Q3 2019TDH HLDGS INC
CUSIP G87084102
—Cmn13,64110,938-2,703$10$16+$62019-11-14
Q3 2019SUNESIS PHARMACEUTICALS INC
CUSIP 867328700
—Cmn29,38820,301-9,087$21$15-$62019-11-14
Q3 2019TELIGENT INC NEW
CUSIP 87960W104
—Cmn30,06414,256-15,808$19$14-$52019-11-14
Q3 2019NAVIOS MARITIME HLDGS INC
CUSIP Y62197119
—Cmn13,03012,831-199$58$62+$42019-11-14
Q3 201922ND CENTY GROUP INC
CUSIP 90137F103
—Cmn75,15771,276-3,881$157$161+$42019-11-14
Q3 2019CELLECT BIOTECHNOLOGY LTD
CUSIP 15116C102
—Depository Receipt28,60425,147-3,457$15$12-$32019-11-14
Q3 2019STEEL CONNECT INC
CUSIP 858098106
—Cmn19,40518,764-641$35$32-$32019-11-14
Q3 2019REVOLUTION LIGHTING TECHNOLO
CUSIP 76155G206
—Cmn43,16136,851-6,310$11$9-$22019-11-14